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Abstract 
 3
This thesis presents a randomised controlled trial of the Lidcombe Program of 
Early Stuttering Intervention. The Lidcombe Program was developed for the 
treatment of stuttering in preschool-age children. The effectiveness of the Lidcombe 
Program was compared to a control group in a parallel group randomised controlled 
trial with blinded outcome assessment. A number of supplementary studies were 
conducted in support of the trial; two literature reviews, two retrospective file audits 
and a statistical simulation study.   
A review of randomised studies of treatments for stuttering showed that there 
have been 27 such studies published in English language journals. Of these only one 
was devoted to a treatment for early stuttering and that was the Lidcombe Program. 
The randomised study showed that 3 months of this treatment was associated with a 
lower level of stuttering compared to a control group who received no treatment. 
However, with a sample size of 23, this study lacked power and the children did not 
receive a full course of treatment.  Despite these limitations, this study provided 
evidence that a medium to large effect size could be anticipated in an adequately 
powered and properly conducted randomised controlled trial. 
Two retrospective file audit studies of children treated with the Lidcombe 
Program were conducted in Australia and Britain. One purpose of these file audits 
was to obtain information relevant to the design and conduct of the randomised 
controlled trial. Data from the case reports on more than 300 children from the two 
sites were included in a meta-analysis. Results showed that a median of 11 weekly 
clinic sessions were required for children to attain the criteria for low levels of 
stuttering for completion of Stage 1 of the Lidcombe Program. Approximately 90% 
of children had achieved those criteria within 6 months of beginning treatment and 
almost all children had achieved them within 1 year.  
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There were two treatment sites for the randomised controlled trial: the 
University of Canterbury (Christchurch, New Zealand) and the Stuttering Treatment 
and Research Trust (Auckland, New Zealand). A total of 54 preschool-age children 
were recruited: 29 to the Lidcombe Program and 25 to the control group. Analysis 
with t-test showed a highly statistically significant difference (p = 0.003) at 9-months 
post-randomisation. The mean percentage of syllables stuttered (%SS) at 9-months 
post-randomisation was 1.5 (SD = 1.4) for the Lidcombe Program group compared to 
3.9 (SD = 3.5) for the control group, resulting in a treatment effect of 2.3 %SS (95% 
confidence interval: 0.8-3.9). This treatment effect was more than double the 
minimum clinically worthwhile difference specified in the trial protocol. These 
results show that the Lidcombe Program is significantly more effective than natural 
recovery for reducing stuttering levels in preschool children. The Lidcombe Program 
is the first early stuttering treatment to be shown to be more effective than natural 
recovery in a randomised controlled trial. 
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Preface 
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The section in Chapter 2 describing randomised controlled trials was largely 
taken from the publication by Jones, Gebski, Onslow, and Packman (2001). The 
majority of the material included in Chapter 3 was published as Jones, Onslow, 
Packman, and Gebski (2002). Mark Onslow proposed the survey of studies published 
in the Journal of Speech, Language and Hearing Research and the Journal of Fluency 
Disorders, and the author conducted the survey and wrote the manuscript. The other 
three authors assisted with writing the manuscript.  
The two retrospective studies described in Chapters 4 and 5 were published 
as Jones, Onslow, Harrison, and Packman (2000) and Kingston, Onslow, Huber, 
Jones, and Packman (2003). For the first study, Elisabeth Harrison was responsible 
for the data collection and treatment of some of the children. The author provided 
statistical analysis and contributed significantly to the scientific content of the 
manuscript. All four authors contributed to writing the manuscript under the 
direction of Mark Onslow. Mary Kingston was responsible for treatment of the 
children and data collection in the second study. The author contributed statistical 
analysis including the meta-analysis of the two studies. The five authors wrote the 
manuscript with Anna Huber being in charge of collating the ideas from the other 
authors and writing the original draft.  
A very preliminary version of the study outlined in Chapter 6 was presented 
as Jones (2002). The study as outlined in Chapter 6 has been submitted for 
publication as Jones, Onslow, Packman, and Gebski (2005). The author designed and 
conducted the study with methodological guidance from Val Gebski and clinical 
input from Mark Onslow and Ann Packman. The manuscript was written by the 
author with assistance from the other three authors.  
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The randomised controlled trial of the Lidcombe Program included in 
Chapter 7 was approved by the University of Sydney Ethics Committee and the 
University of Canterbury Ethics Committee. The design of the trial has been 
presented or published on three previous occasions: Jones, Gebski, Onslow, and 
Packman (2000); Jones, Gebski, Onslow, and Packman (2001); and Jones, Blakely, 
and Ormond (2003). Results from the trial have also been written up in a manuscript 
and recently published as Jones, Onslow, Packman, Williams, Ormond, Schwarz, 
and Gebski (2005). The author was responsible for the design and analysis of the trial 
with methodological input from Val Gebski and clinical input from Mark Onslow 
and Ann Packman. Tika Ormond and Shelley Williams treated the children as well as 
collected and rated the tapes of the children’s speech. Writing of the manuscripts, 
book chapter and presentation was conducted by the author with assistance from the 
co-authors as listed above.  
No part of this thesis has been submitted for any other degree at any other 
institution. 
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